The current state, challenges and future directions of DBS for OCD
UF Health neurologists lead review of the use of deep brain stimulation to treat OCD.
UF Health neurologists lead review of the use of deep brain stimulation to treat OCD.
Working in the lab of Dr. Natalie Ebner, Pehlivanoglu is focused on understanding whether people become more susceptible to deception in advanced age and, if so, identifying any cognitive, socioemotional and neurobiological mechanisms behind it.
In Newsweek, Dr. Michael Okun weighs in on why some individuals may experience "freezing."
In Neurology Today, UF neurologist Dr. Irene Malaty emphasized the importance of managing coexisting conditions.
Zachary Simon, a PhD student in the lab of Dr. Marcelo Febo, has been accepted into the Society for Neuroscience’s Scholar Program.
Dr. Ebner is the principal investigator of the Social-Cognitive and Affective Development Lab.
In The Conversation, UF neuroscientist Dr. Habibeh Khoshbouei explains the science behind the controversial ADHD drug.
Scientists at The Wertheim UF Scripps Institute report that a common amino acid can deliver a “slow-down” signal to the brain, likely influencing major depression, anxiety and other mood disorders in some people.
Dr. Gary Reisfield explains the potential impact of poppy seeds on drug tests for Fox News article.
Dr. Dawn-Christi Bruijnzeel discusses the importance of street psychiatry for Psychiatric News article.